PH12018500817A1 - Pharmaceutical composition comprising metformin and lobeglitazone - Google Patents

Pharmaceutical composition comprising metformin and lobeglitazone

Info

Publication number
PH12018500817A1
PH12018500817A1 PH12018500817A PH12018500817A PH12018500817A1 PH 12018500817 A1 PH12018500817 A1 PH 12018500817A1 PH 12018500817 A PH12018500817 A PH 12018500817A PH 12018500817 A PH12018500817 A PH 12018500817A PH 12018500817 A1 PH12018500817 A1 PH 12018500817A1
Authority
PH
Philippines
Prior art keywords
pharmaceutical composition
lobeglitazone
metformin
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
PH12018500817A
Other languages
English (en)
Inventor
Eun Ji Shin
Min Kwan Cho
Teak Hwan Shin
Shin Jung Park
Jong Lae Lim
Original Assignee
Chong Kun Dang Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chong Kun Dang Pharmaceutical Corp filed Critical Chong Kun Dang Pharmaceutical Corp
Publication of PH12018500817A1 publication Critical patent/PH12018500817A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH12018500817A 2015-10-28 2018-04-16 Pharmaceutical composition comprising metformin and lobeglitazone PH12018500817A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150150108A KR101750690B1 (ko) 2015-10-28 2015-10-28 메트포르민 및 로베글리타존을 포함하는 약제학적 조성물
PCT/KR2016/009393 WO2017073897A1 (en) 2015-10-28 2016-08-24 Pharmaceutical composition comprising metformin and lobeglitazone

Publications (1)

Publication Number Publication Date
PH12018500817A1 true PH12018500817A1 (en) 2018-10-29

Family

ID=58630531

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12018500817A PH12018500817A1 (en) 2015-10-28 2018-04-16 Pharmaceutical composition comprising metformin and lobeglitazone

Country Status (3)

Country Link
KR (1) KR101750690B1 (ko)
PH (1) PH12018500817A1 (ko)
WO (1) WO2017073897A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102369679B1 (ko) * 2017-09-29 2022-03-04 한미약품 주식회사 다파글리플로진 l-프롤린과 메트포르민을 포함하는 약제학적 복합제제
KR102070104B1 (ko) * 2018-06-05 2020-01-29 주식회사 종근당 메트포르민 및 로베글리타존을 포함하는 서방성 약제학적 제제
KR20240041755A (ko) * 2022-09-23 2024-04-01 주식회사 종근당 제2형 당뇨병 치료용 조성물 및 병용 요법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20010230A1 (it) * 2001-11-29 2003-05-29 Menarini Int Operations Lu Sa Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
KR101363679B1 (ko) * 2002-09-20 2014-02-14 안드렉스 랩스 엘엘씨 약제학적 정제
KR100812538B1 (ko) 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제

Also Published As

Publication number Publication date
KR20170049129A (ko) 2017-05-10
WO2017073897A1 (en) 2017-05-04
KR101750690B1 (ko) 2017-06-27

Similar Documents

Publication Publication Date Title
MX2018003388A (es) Agonistas del receptor farnesoide x y usos de los mismos.
MX2015016983A (es) Moduladores del transporte nuclear y usos de los mismos.
MX370792B (es) Composiciones para usarse en el tratamiento de cáncer.
PH12015502616A1 (en) Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
MX2018000546A (es) Composiciones farmaceuticas que contienen celecoxib y tramadol.
WO2014153009A3 (en) Thiosaccharide mucolytic agents
PH12017501084A1 (en) Insulin glargine/lixisenatide fixed ratio formulation
MX2021008432A (es) Composiciones farmaceuticas y usos dirigidos a los trastornos del almacenamiento lisosomal.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2016014696A (es) Combinaciones de formoterol y budesonida para el tratamiento de enfermedad pulmonar obstructiva cronica.
MX2021010041A (es) Composiciones farmaceuticas que comprenden inhibidores de la proteina quinasa akt.
PH12018500817A1 (en) Pharmaceutical composition comprising metformin and lobeglitazone
MX2020012989A (es) Agente terapeutico para la fibrosis.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
BR112017014295A2 (pt) composição farmacêutica.
MX2018015240A (es) Composiciones que comprenden timolol y su uso en el tratamiento de rosacea mediante administracion topica.
AR106415A1 (es) Composición farmacéutica para el tratamiento del dolor
MX2023005681A (es) Composicion farmaceutica para el tratamiento contra el dolor agudo y cronico, que contiene polmacoxib y tramadol.
PH12018500946A1 (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
UA109242U (uk) Стабільна фармацевтична композиція, що містить інгібітор протеасом
MX2016010919A (es) 4-bencilsulfonil-2-butenonitrilo.
GR1008804B (el) Συνθεσεις για ιατρικη χρηση οι οποιες περιλαμβανουν υαλουρονικο οξυ ή αλατα αυτου, αμινοξεα, βιταμινες, ανοργανα αλατα και αλλα συστατικα
IN2014DE00822A (ko)